Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous gene therapy. Principles and prospects.

M T Lin1, L Pulkkinen, J Uitto

  • 1Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.

Dermatologic Clinics
|January 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation reports: epidermolysis bullosa simplex associated with severe mucous membrane involvement and novel mutations in the plectin gene.

The Journal of investigative dermatology·2000
Same author

Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy.

The Journal of investigative dermatology·2000
Same author

Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel mutations in keratin 12 (K12) and complete sequence of the human KRT12 gene.

Experimental eye research·2000
Same author

Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa.

The Journal of investigative dermatology·2000
Same author

Combination of novel premature termination codon and glycine substitution mutations in COL7A1 leads to moderately severe recessive dystrophic epidermolysis bullosa.

The Journal of investigative dermatology·2000
Same author

A novel mutation in the helix termination motif of keratin K12 in a US family with Meesmann corneal dystrophy.

American journal of ophthalmology·1999
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Gene therapy is increasingly important for dermatologists, with new applications in cancer therapy and vaccination beyond gene replacement. Various gene delivery systems are under investigation for treating skin diseases.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy is gaining traction in dermatology, bridging basic research and clinical applications.
  • Advances in gene-based cancer therapy, DNA vaccination, and molecular pharmacology are expanding its scope.
  • Traditional gene replacement is no longer the sole focus of gene therapy research.

Purpose of the Study:

  • To summarize the principles of gene therapy.
  • To review current and potential applications of gene therapy in cutaneous diseases.
  • To discuss the advantages and disadvantages of different gene delivery systems.

Main Methods:

  • Review of current literature on gene therapy principles and applications.
  • Analysis of various gene delivery systems.

Related Experiment Videos

  • Focus on advancements relevant to dermatological conditions.

    • Main Results:

    • Gene therapy offers novel approaches for skin conditions, including cancer and infectious diseases.
    • Diverse gene delivery systems exist, each with unique benefits and drawbacks.
    • The field is rapidly evolving beyond traditional gene replacement.

    Conclusions:

    • Gene therapy holds significant promise for treating a range of cutaneous diseases.
    • Understanding gene therapy principles and delivery systems is crucial for dermatologists.
    • Continued research is essential to optimize gene therapy for skin applications.